Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 574 entries
Sorted by: Best Match Show Resources per page
'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women

gender (e.g., male, women, girls, transgender)

Sevelius JM, Arnold E.
GSID: B1hWmtjC0cQJ
JM Sevelius, JA Keatley, N Calma, E Arnold - Global public health, 2016 - Taylor & Francis

… gender-based oppression (eg Global Action for Trans* … and/or female gender identity who were assigned male sex at … I mean, how many girls in this room know someone working …

Cite
Sevelius, J. M., Keatley, J., Calma, N., & Arnold, E. (2016). ‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Global public health, 11(7-8), 1060-1075.
Sevelius, Jae M., et al. "‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender women." Global public health 11.7-8 (2016): 1060-1075.
Copy Download .nbib Format: MLA
Women in medicine--50 years of progress.

Medical affairs

Arnold AW.
PMID: 5287406
Med Aff. 1971;(37):2-7.

No abstract available.

Cite
Arnold AW. Women in medicine--50 years of progress. Med Aff. 1971;(37):2-7
Arnold, A. W. (1971). Women in medicine--50 years of progress. Medical affairs, (37), 2-7.
Arnold, A W. "Women in medicine--50 years of progress." Medical affairs vol. ,37 (1971): 2-7.
Arnold AW. Women in medicine--50 years of progress. Med Aff. 1971;(37):2-7. PMID: 5287406.
Copy Download .nbib Format: NLM
A review of complementary and alternative treatments for autism spectrum disorders.

Autism research and treatment

Lofthouse N, Hendren R, Hurt E, Arnold LE, Butter E.
PMID: 23243505
Autism Res Treat. 2012;2012:870391. doi: 10.1155/2012/870391. Epub 2012 Nov 28.

Given the severe and chronic problems associated with Autism Spectrum Disorders (ASD) and the limitations of available treatments, there exists a large public health need for additional interventions. As more parents are inquiring about complementary and alternative treatments (CATs),...

Cite
Lofthouse N, Hendren R, Hurt E, et al. A review of complementary and alternative treatments for autism spectrum disorders. Autism Res Treat. 2012;2012:870391doi: 10.1155/2012/870391.
Lofthouse, N., Hendren, R., Hurt, E., Arnold, L. E., & Butter, E. (2012). A review of complementary and alternative treatments for autism spectrum disorders. Autism research and treatment, 2012870391. https://doi.org/10.1155/2012/870391
Lofthouse, Nicholas, et al. "A review of complementary and alternative treatments for autism spectrum disorders." Autism research and treatment vol. 2012 (2012): 870391. doi: https://doi.org/10.1155/2012/870391
Lofthouse N, Hendren R, Hurt E, Arnold LE, Butter E. A review of complementary and alternative treatments for autism spectrum disorders. Autism Res Treat. 2012;2012:870391. doi: 10.1155/2012/870391. Epub 2012 Nov 28. PMID: 23243505; PMCID: PMC3515887.
Copy Download .nbib Format: NLM
APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum.

Oncotarget

Mavlyutov TA, Yang H, Epstein ML, Ruoho AE, Yang J, Guo LW.
PMID: 28881650
Oncotarget. 2017 May 16;8(31):51317-51330. doi: 10.18632/oncotarget.17906. eCollection 2017 Aug 01.

The sigma-1 receptor (Sig1R) is an endoplasmic reticulum chaperonin that is attracting tremendous interest as a potential anti-neurodegenerative target. While this membrane protein is known to reside in the inner nuclear envelope (NE) and influences transcription, apparent Sig1R presence...

Cite
Mavlyutov TA, Yang H, Epstein ML, et al. APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum. Oncotarget. 2017;8(31):51317-51330doi: 10.18632/oncotarget.17906.
Mavlyutov, T. A., Yang, H., Epstein, M. L., Ruoho, A. E., Yang, J., & Guo, L. W. (2017). APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum. Oncotarget, 8(31), 51317-51330. https://doi.org/10.18632/oncotarget.17906
Mavlyutov, Timur A, et al. "APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum." Oncotarget vol. 8,31 (2017): 51317-51330. doi: https://doi.org/10.18632/oncotarget.17906
Mavlyutov TA, Yang H, Epstein ML, Ruoho AE, Yang J, Guo LW. APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum. Oncotarget. 2017 May 16;8(31):51317-51330. doi: 10.18632/oncotarget.17906. eCollection 2017 Aug 01. PMID: 28881650; PMCID: PMC5584251.
Copy Download .nbib Format: NLM
An immunocompetent mouse model of human glioblastoma.

Oncotarget

Semenkow S, Li S, Kahlert UD, Raabe EH, Xu J, Arnold A, Janowski M, Oh BC, Brandacher G, Bulte JWM, Eberhart CG, Walczak P.
PMID: 28977847
Oncotarget. 2017 May 15;8(37):61072-61082. doi: 10.18632/oncotarget.17851. eCollection 2017 Sep 22.

Orthotopic xenotransplantation studies represent the final stage in preclinical cancer research and could facilitate the implementation of precision medicine. To date, these xenografts have been tested in immunodeficient animals, but complete elimination of the adaptive immunity is a significant...

Cite
Semenkow S, Li S, Kahlert UD, et al. An immunocompetent mouse model of human glioblastoma. Oncotarget. 2017;8(37):61072-61082doi: 10.18632/oncotarget.17851.
Semenkow, S., Li, S., Kahlert, U. D., Raabe, E. H., Xu, J., Arnold, A., Janowski, M., Oh, B. C., Brandacher, G., Bulte, J. W. M., Eberhart, C. G., & Walczak, P. (2017). An immunocompetent mouse model of human glioblastoma. Oncotarget, 8(37), 61072-61082. https://doi.org/10.18632/oncotarget.17851
Semenkow, Samantha, et al. "An immunocompetent mouse model of human glioblastoma." Oncotarget vol. 8,37 (2017): 61072-61082. doi: https://doi.org/10.18632/oncotarget.17851
Semenkow S, Li S, Kahlert UD, Raabe EH, Xu J, Arnold A, Janowski M, Oh BC, Brandacher G, Bulte JWM, Eberhart CG, Walczak P. An immunocompetent mouse model of human glioblastoma. Oncotarget. 2017 May 15;8(37):61072-61082. doi: 10.18632/oncotarget.17851. eCollection 2017 Sep 22. PMID: 28977847; PMCID: PMC5617407.
Copy Download .nbib Format: NLM
Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART): Design and Methods.

Vision development and rehabilitation

, Scheiman M, Mitchell GL, Cotter SA, Kulp M, Chase C, Borsting E, Arnold E, Denton C, Hertle R.
PMID: 26942226
Vis Dev Rehabil. 2015 Oct;1(3):214-228.

OBJECTIVE: To describe the design and methodology of the Convergence Insufficiency Treatment Trial: Attention and Reading Trial (CITT-ART), the first randomized clinical trial evaluating the effect of vision therapy on reading and attention in school-age children with symptomatic convergence...

Cite
, Scheiman M, Mitchell GL, et al. Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART): Design and Methods. Vis Dev Rehabil. 2015;1(3):214-228
, Scheiman, M., Mitchell, G. L., Cotter, S. A., Kulp, M., Chase, C., Borsting, E., Arnold, E., Denton, C., & Hertle, R. (2015). Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART): Design and Methods. Vision development and rehabilitation, 1(3), 214-228.
, et al. "Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART): Design and Methods." Vision development and rehabilitation vol. 1,3 (2015): 214-228.
, Scheiman M, Mitchell GL, Cotter SA, Kulp M, Chase C, Borsting E, Arnold E, Denton C, Hertle R. Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART): Design and Methods. Vis Dev Rehabil. 2015 Oct;1(3):214-228. PMID: 26942226; PMCID: PMC4772970.
Copy Download .nbib Format: NLM
High-precision control of static magnetic field magnitude, orientation, and gradient using optically pumped vapour cell magnetometry.

The Review of scientific instruments

Ingleby SJ, Griffin PF, Arnold AS, Chouliara M, Riis E.
PMID: 28456251
Rev Sci Instrum. 2017 Apr;88(4):043109. doi: 10.1063/1.4980159.

An integrated system of hardware and software allowing precise definition of arbitrarily oriented magnetic fields up to |B| = 1 μT within a five-layer Mumetal shield is described. The system is calibrated with reference to magnetic resonance observed between...

Cite
Ingleby SJ, Griffin PF, Arnold AS, et al. High-precision control of static magnetic field magnitude, orientation, and gradient using optically pumped vapour cell magnetometry. Rev Sci Instrum. 2017;88(4):043109doi: 10.1063/1.4980159.
Ingleby, S. J., Griffin, P. F., Arnold, A. S., Chouliara, M., & Riis, E. (2017). High-precision control of static magnetic field magnitude, orientation, and gradient using optically pumped vapour cell magnetometry. The Review of scientific instruments, 88(4), 043109. https://doi.org/10.1063/1.4980159
Ingleby, S J, et al. "High-precision control of static magnetic field magnitude, orientation, and gradient using optically pumped vapour cell magnetometry." The Review of scientific instruments vol. 88,4 (2017): 043109. doi: https://doi.org/10.1063/1.4980159
Ingleby SJ, Griffin PF, Arnold AS, Chouliara M, Riis E. High-precision control of static magnetic field magnitude, orientation, and gradient using optically pumped vapour cell magnetometry. Rev Sci Instrum. 2017 Apr;88(4):043109. doi: 10.1063/1.4980159. PMID: 28456251.
Copy Download .nbib Format: NLM
Oxidative stress, activity behaviour and body mass in captive parrots.

Conservation physiology

Larcombe SD, Tregaskes CA, Coffey J, Stevenson AE, Alexander LG, Arnold KE.
PMID: 27293729
Conserv Physiol. 2015 Oct 20;3(1):cov045. doi: 10.1093/conphys/cov045. eCollection 2015.

Many parrot species are kept in captivity for conservation, but often show poor reproduction, health and survival. These traits are known to be influenced by oxidative stress, the imbalance between the production of reactive oxygen species (ROS) and ability...

Cite
Larcombe SD, Tregaskes CA, Coffey J, et al. Oxidative stress, activity behaviour and body mass in captive parrots. Conserv Physiol. 2015;3(1):cov045doi: 10.1093/conphys/cov045.
Larcombe, S. D., Tregaskes, C. A., Coffey, J., Stevenson, A. E., Alexander, L. G., & Arnold, K. E. (2015). Oxidative stress, activity behaviour and body mass in captive parrots. Conservation physiology, 3(1), cov045. https://doi.org/10.1093/conphys/cov045
Larcombe, S D, et al. "Oxidative stress, activity behaviour and body mass in captive parrots." Conservation physiology vol. 3,1 (2015): cov045. doi: https://doi.org/10.1093/conphys/cov045
Larcombe SD, Tregaskes CA, Coffey J, Stevenson AE, Alexander LG, Arnold KE. Oxidative stress, activity behaviour and body mass in captive parrots. Conserv Physiol. 2015 Oct 20;3(1):cov045. doi: 10.1093/conphys/cov045. eCollection 2015. PMID: 27293729; PMCID: PMC4778434.
Copy Download .nbib Format: NLM
Rapid experimental SAD phasing and hot-spot identification with halogenated fragments.

IUCrJ

Bauman JD, Harrison JJ, Arnold E.
PMID: 26870381
IUCrJ. 2016 Jan 01;3:51-60. doi: 10.1107/S2052252515021259. eCollection 2016 Jan 01.

Through X-ray crystallographic fragment screening, 4-bromopyrazole was discovered to be a 'magic bullet' that is capable of binding at many of the ligand 'hot spots' found in HIV-1 reverse transcriptase (RT). The binding locations can be in pockets that...

Cite
Bauman JD, Harrison JJ, Arnold E. Rapid experimental SAD phasing and hot-spot identification with halogenated fragments. IUCrJ. 2016;3:51-60doi: 10.1107/S2052252515021259.
Bauman, J. D., Harrison, J. J., & Arnold, E. (2016). Rapid experimental SAD phasing and hot-spot identification with halogenated fragments. IUCrJ, 351-60. https://doi.org/10.1107/S2052252515021259
Bauman, Joseph D, et al. "Rapid experimental SAD phasing and hot-spot identification with halogenated fragments." IUCrJ vol. 3 (2016): 51-60. doi: https://doi.org/10.1107/S2052252515021259
Bauman JD, Harrison JJ, Arnold E. Rapid experimental SAD phasing and hot-spot identification with halogenated fragments. IUCrJ. 2016 Jan 01;3:51-60. doi: 10.1107/S2052252515021259. eCollection 2016 Jan 01. PMID: 26870381; PMCID: PMC4704079.
Copy Download .nbib Format: NLM
Assessing change in core autism symptoms: challenges for pharmacological studies.

Journal of child and adolescent psychopharmacology

Aman MG, Arnold LE, Hollway JA.
PMID: 25978740
J Child Adolesc Psychopharmacol. 2015 May;25(4):282-5. doi: 10.1089/cap.2015.28999.mga.

No abstract available.

Cite
Aman MG, Arnold LE, Hollway JA. Assessing change in core autism symptoms: challenges for pharmacological studies. J Child Adolesc Psychopharmacol. 2015;25(4):282-5doi: 10.1089/cap.2015.28999.mga.
Aman, M. G., Arnold, L. E., & Hollway, J. A. (2015). Assessing change in core autism symptoms: challenges for pharmacological studies. Journal of child and adolescent psychopharmacology, 25(4), 282-5. https://doi.org/10.1089/cap.2015.28999.mga
Aman, Michael G, et al. "Assessing change in core autism symptoms: challenges for pharmacological studies." Journal of child and adolescent psychopharmacology vol. 25,4 (2015): 282-5. doi: https://doi.org/10.1089/cap.2015.28999.mga
Aman MG, Arnold LE, Hollway JA. Assessing change in core autism symptoms: challenges for pharmacological studies. J Child Adolesc Psychopharmacol. 2015 May;25(4):282-5. doi: 10.1089/cap.2015.28999.mga. PMID: 25978740.
Copy Download .nbib Format: NLM
Recurrent ZFX mutations in human sporadic parathyroid adenomas.

Oncoscience

Soong CP, Arnold A.
PMID: 25594030
Oncoscience. 2014 May 06;1(5):360-6. doi: 10.18632/oncoscience.116. eCollection 2014.

The molecular abnormalities leading to sporadic parathyroid adenomas, a common type of human endocrine neoplasm, are heterogeneous and incompletely understood. Using whole exome and direct sequencing of parathyroid adenoma DNA samples, we identified recurrent somatic mutations in the ZFX...

Cite
Soong CP, Arnold A. Recurrent ZFX mutations in human sporadic parathyroid adenomas. Oncoscience. 2014;1(5):360-6doi: 10.18632/oncoscience.116.
Soong, C. P., & Arnold, A. (2014). Recurrent ZFX mutations in human sporadic parathyroid adenomas. Oncoscience, 1(5), 360-6. https://doi.org/10.18632/oncoscience.116
Soong, Chen-Pang, and Arnold, Andrew. "Recurrent ZFX mutations in human sporadic parathyroid adenomas." Oncoscience vol. 1,5 (2014): 360-6. doi: https://doi.org/10.18632/oncoscience.116
Soong CP, Arnold A. Recurrent ZFX mutations in human sporadic parathyroid adenomas. Oncoscience. 2014 May 06;1(5):360-6. doi: 10.18632/oncoscience.116. eCollection 2014. PMID: 25594030; PMCID: PMC4278311.
Copy Download .nbib Format: NLM
Pathogenesis of Systemic Sclerosis.

Frontiers in immunology

Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE.
PMID: 26106387
Front Immunol. 2015 Jun 08;6:272. doi: 10.3389/fimmu.2015.00272. eCollection 2015.

Systemic scleroderma (SSc) is one of the most complex systemic autoimmune diseases. It targets the vasculature, connective tissue-producing cells (namely fibroblasts/myofibroblasts), and components of the innate and adaptive immune systems. Clinical and pathologic manifestations of SSc are the result...

Cite
Pattanaik D, Brown M, Postlethwaite BC, et al. Pathogenesis of Systemic Sclerosis. Front Immunol. 2015;6:272doi: 10.3389/fimmu.2015.00272.
Pattanaik, D., Brown, M., Postlethwaite, B. C., & Postlethwaite, A. E. (2015). Pathogenesis of Systemic Sclerosis. Frontiers in immunology, 6272. https://doi.org/10.3389/fimmu.2015.00272
Pattanaik, Debendra, et al. "Pathogenesis of Systemic Sclerosis." Frontiers in immunology vol. 6 (2015): 272. doi: https://doi.org/10.3389/fimmu.2015.00272
Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pathogenesis of Systemic Sclerosis. Front Immunol. 2015 Jun 08;6:272. doi: 10.3389/fimmu.2015.00272. eCollection 2015. PMID: 26106387; PMCID: PMC4459100.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 574 entries